Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Gamma-Aminobutyric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gamma-Aminobutyric Acid SCHEMBL463251 | 1.00 | — | — | |
| Gamma-Aminobutyric Acid SCHEMBL21296991 | 0.97 | — | — | |
| Gamma-Aminobutyric Acid SCHEMBL4878 | 0.97 | — | — | |
| Gamma-Aminobutyric Acid SCHEMBL190459 | 0.97 | LMNA (1.00) | — | |
| Gamma-Aminobutyric Acid SCHEMBL3973563 | 0.97 | LMNA (1.00) | — | |
| Gamma-Aminobutyric Acid SCHEMBL1330421 | 0.97 | — | — | |
| Gamma-Aminobutyric Acid SCHEMBL3017607 | 0.94 | LMNA (0.83) | — | |
| Gamma-Aminobutyric Acid SCHEMBL25327475 | 0.94 | — | — | |
| Gamma-Aminobutyric Acid SCHEMBL20593982 | 0.94 | — | — | |
| Gamma-Aminobutyric Acid SCHEMBL2768665 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 511 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122031551-A | Radix puerariae liver-protecting composition and preparation method and application thereof | 湘西百草生物科技有限责任公司 | 2026-05-15 | — | — | CN | claimed |
| CN-116554043-B | Process for the synthesis of 2- (2-aminoethyl) cyclobutan-1-one of 6-aminocaproic acid | 常州兰陵制药有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-118678843-A | Method for improving performance of tin-lead mixed perovskite solar cell | 上海空间电源研究所 | 2024-09-20 | — | — | CN | claimed |
| CN-116554043-A | Process for the synthesis of 2- (2-aminoethyl) cyclobutan-1-one of 6-aminocaproic acid | 常州兰陵制药有限公司 | 2023-08-08 | — | — | CN | claimed |
| WO-2023050002-A1 | PROCESS FOR SYNTHESIS OF ACIDIC SALTS OF AMINES FROM α-AMINO ACIDS AND FORMULATION COMPRISING SUCH AMINE ACIDIC SALTS | SMITH ENNISKILLEN COMPANY LIMITED (CA) | 2023-04-06 | — | — | WO | claimed |
| CN-105001098-A | Method for preparing 3(R)/(S)-amidogen-1-butanol | SHENGZHOU OIL CHEMICAL CO LTD | 2015-10-28 | — | — | CN | claimed |
| US-20130018047-A1 | N-PHENYL-(PIPERAZINYL OR HOMOPIPERAZINYL)-BENZENESULFONAMIDE OR BENZENESULFONYL-PHENYL-(PIPERAZINE OR HOMOPIPERAZINE) COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR | ABBOTT LABORATORIES (US) | 2013-01-17 | — | — | US | claimed |
| CN-102828284-A | Method for preparing high-strength chitosan fiber with binary solvent system | UNIV DONGHUA | 2012-12-19 | — | — | CN | claimed |
| CN-102828283-A | Method for preparing chitosan and cellulose complex fibers by binary solvent system | UNIV DONGHUA | 2012-12-19 | — | — | CN | claimed |
| WO-2008026046-A1 | MORPHOLINE D3 DOPAMINE ANTAGONISTS | PFIZER PRODUCTS INC. (US) | 2008-03-06 | — | — | WO | claimed |
| WO-2005016260-A2 | PRODRUGS FOR THE ORAL AND PARENTERAL DELIVERY OF AMINE-CONTAINING DRUGS, AMINO ACIDS, AND PEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-02-24 | — | — | WO | claimed |
| US-20030180652-A1 | Toner coagulant processes | XEROX CORPORATION | 2003-09-25 | — | — | US | claimed |
| CN-122031551-A | Radix puerariae liver-protecting composition and preparation method and application thereof | 湘西百草生物科技有限责任公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12590062-B2 | PD-1/PD-L1 inhibitors | GILEAD SCIENCES, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-20260015313-A1 | AMINO ACID ACTIVE ESTER AND SALT THEREOF | PEPTIDREAM INC (JP) | 2026-01-15 | — | — | US | disclosed |
| CN-116554043-B | Process for the synthesis of 2- (2-aminoethyl) cyclobutan-1-one of 6-aminocaproic acid | 常州兰陵制药有限公司 | 2025-02-25 | — | — | CN | disclosed |
| EP-0125975-A1 | Diphenylazomethines carrying an esterified chain, their preparation and their therapeutical use | SYNTHELABO (FR) | 1984-11-21 | — | — | EP | disclosed |
| US-4448816-A | N-ISOCYANTOALKANOYL SUBSTITUTED CYCLIC UREAS USED IN POLYURETHANE COATINGS | THE UPJOHN COMPANY (US) | 1984-05-15 | — | — | US | disclosed |
| US-4443616-A | Production of 3-pyrrolin-2-ones | THE PURDUE FREDERICK COMPANY (US) | 1984-04-17 | — | — | US | disclosed |
| EP-0000036-B1 | FLUORINATED ALKYLAMINES AND PROCESS FOR PREPARING SAME | MERCK & CO. INC. (US) | 1981-10-14 | — | — | EP | disclosed |